* 泰国富豪谢氏家族旗下制药公司--中国生物制药1177.HK周五早盘一度升4.8%，LM-350获美国FDA新药临床试验批件。
* 该公司此前公告，自主研发的LM-350“CDH17 ADC”获得美国FDA的IND批件。
* 中国生物制药今年迄今劲涨118.4%，同期恒生指数.HSI大幅上扬27.2%。
* 恒生香港上市生物科技指数.HSHKBIO盘中涨1.2%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 崔珠珠；审校 杨淑祯)
((zhuzhu.cui@thomsonreuters.com; +86-21-20830048;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.